TerminatedNCT01368458
Conversion to Antipsychotic Monotherapy
Interventional studyAges 18–75Schizophrenia
Understand this study
Who could participate?
This study is for people with schizophrenia. Listed age limits: 18 years to 75 years. Other eligibility criteria apply.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateDecember 2007
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 24
- Sponsor
- Nathan Kline Institute for Psychiatric Research
- Sponsor type
- Research institute
- Study type
- Other
- Intervention type
- Other
- Locations
- Not clearly listed
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT01368458
- Official title
Show the full official title
A Randomized, Rater-Blind, Controlled, Clinical Trial of Conversion to Antipsychotic Monotherapy vs. Continued Polypharmacy for Patients With Schizophrenia or Schizoaffective Disorder
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Locations not listed
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Nathan Kline Institute for Psychiatric Research, a research institute.
Who can participate?
This study is for people with schizophrenia. Listed age limits: 18 years to 75 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as terminated.
